ClinicalTrials.Veeva

Menu

Quality-Of-Life Assessment in Patients With Head and Neck Cancer Treated With Radiation Therapy

C

Centre Georges Francois Leclerc

Status

Unknown

Conditions

Head and Neck Cancer

Treatments

Other: questionnaire administration
Procedure: quality-of-life assessment
Procedure: standard follow-up care

Study type

Observational

Funder types

Other

Identifiers

NCT01210872
CGFL-QDV
CGFL-AFSSAPS-2008-A01468-47
CDR0000683850 (Registry Identifier)
EU-21061

Details and patient eligibility

About

RATIONALE: Gathering information over time about patients' quality-of-life and satisfaction with care may help doctors plan the best treatment and help patients live more comfortably.

PURPOSE: This randomized clinical trial is studying quality-of-life assessment in patients with head and neck cancer treated with radiation therapy.

Full description

OBJECTIVES:

Primary

  • To evaluate the impact of quality-of-life assessment in routine oncology practice on satisfaction with care, health-related quality-of-life, and toxicity in patients with primary nonmetastatic head and neck cancer treated with radiotherapy.

Secondary

  • To evaluate the feasibility of using quality-of-life tools in routine oncology practice.
  • To evaluate the impact on the occurrence of toxicity.
  • To determine the impact on overall survival.
  • To study the concordance between the toxicity reported by the clinician and those reported by the patient quality-of-life questionnaires.

OUTLINE: Patients are stratified according to sex, tumor localization, and TNM stage. Patients are randomized to 1 of 2 arms.

  • Arm I: Patients complete quality-of-life questionnaires (EORTC tools only, including EORTC QLQ-SAT32, EORTC QLQ-C30, and specific module QLQ-H&N35/Euroqol EQ-5D) before each consultation with the clinician for one year.
  • Arm II: Patients undergo standard follow-up care comprising consultation with the clinician for one year.

After completion of study, patients are followed up every 3 months for 1 year and then at 2 years.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

DISEASE CHARACTERISTICS:

  • Diagnosis of primary nonmetastatic head and neck cancer
  • No other primary cancer localizations
  • No second tumor localization at the time of diagnosis
  • Must be planning to be treated initially with radiotherapy

PATIENT CHARACTERISTICS:

  • No cognitive impairment or psychiatric history
  • No history of other cancer

PRIOR CONCURRENT THERAPY:

  • No prior chemotherapy or radiotherapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems